<DOC>
	<DOCNO>NCT00395551</DOCNO>
	<brief_summary>The purpose study determine whether ranibizumab effective treatment choroidal neovascularization secondary cause wet macular-degeneration .</brief_summary>
	<brief_title>Safety Study Ranibizumab Eye Injections Treat Choroidal Neovascularization That Was Caused Other Than Age-Related Macular Degeneration .</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>active choroidal neovascularization pregnancy , agerelated macular degeneration , current eye infection recent eye surgery , participate eye study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>choroidal neovascularization</keyword>
	<keyword>Choroidal Neovascularization Not related Age-Related Macular Degeneration</keyword>
</DOC>